These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23712732)

  • 1. Investigation of the role of transporters on the hepatic elimination of an LAT1 selective inhibitor JPH203.
    Toyoshima J; Kusuhara H; Wempe MF; Endou H; Sugiyama Y
    J Pharm Sci; 2013 Sep; 102(9):3228-38. PubMed ID: 23712732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound.
    Wempe MF; Rice PJ; Lightner JW; Jutabha P; Hayashi M; Anzai N; Wakui S; Kusuhara H; Sugiyama Y; Endou H
    Drug Metab Pharmacokinet; 2012; 27(1):155-61. PubMed ID: 21914964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JPH203, an L-type amino acid transporter 1-selective compound, induces apoptosis of YD-38 human oral cancer cells.
    Yun DW; Lee SA; Park MG; Kim JS; Yu SK; Park MR; Kim SG; Oh JS; Kim CS; Kim HJ; Kim JS; Chun HS; Kanai Y; Endou H; Wempe MF; Kim DK
    J Pharmacol Sci; 2014; 124(2):208-17. PubMed ID: 24492461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function.
    Okunushi K; Furihata T; Morio H; Muto Y; Higuchi K; Kaneko M; Otsuka Y; Ohno Y; Watanabe Y; Reien Y; Nakagawa K; Sakamoto S; Wakashin H; Shimojo N; Anzai N
    J Pharmacol Sci; 2020 Sep; 144(1):16-22. PubMed ID: 32653341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
    Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
    Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
    Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.
    Okano N; Naruge D; Kawai K; Kobayashi T; Nagashima F; Endou H; Furuse J
    Invest New Drugs; 2020 Oct; 38(5):1495-1506. PubMed ID: 32198649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
    Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.
    Muto Y; Furihata T; Kaneko M; Higuchi K; Okunushi K; Morio H; Reien Y; Uesato M; Matsubara H; Anzai N
    Anticancer Res; 2019 Jan; 39(1):159-165. PubMed ID: 30591453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
    Rii J; Sakamoto S; Mizokami A; Xu M; Fujimoto A; Saito S; Koike H; Tamura T; Arai T; Yamada Y; Goto Y; Sazuka T; Imamura Y; Suzuki K; Kanai Y; Anzai N; Ichikawa T
    Cancer Sci; 2024 Mar; 115(3):937-953. PubMed ID: 38186218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturable sinusoidal uptake is rate-determining process in hepatic elimination of docetaxel in rats.
    Yoon I; Han S; Choi YH; Kang HE; Cho HJ; Kim JS; Shim CK; Chung SJ; Chong S; Kim DD
    Xenobiotica; 2012 Nov; 42(11):1110-9. PubMed ID: 22747239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats.
    Fukuda H; Ohashi R; Ohashi N; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2010 Sep; 38(9):1505-13. PubMed ID: 20538722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
    Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
    Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
    Yothaisong S; Dokduang H; Anzai N; Hayashi K; Namwat N; Yongvanit P; Sangkhamanon S; Jutabha P; Endou H; Loilome W
    Tumour Biol; 2017 Mar; 39(3):1010428317694545. PubMed ID: 28347255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic uptake of hematoporphyrin monomethyl ether isomers.
    Li XL; Guo ZT; Wang YD; Chen XY; Liu J; Zhong DF
    Acta Pharmacol Sin; 2015 Feb; 36(2):268-80. PubMed ID: 25418376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uptake of epirubicin by isolated rat hepatocytes and its biliary excretion after intravenous infusion in rats.
    Shin DH; Park SH; Jeong SW; Park CW; Han K; Chung YB
    Arch Pharm Res; 2014 Dec; 37(12):1599-606. PubMed ID: 25373308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
    Saito S; Ando K; Sakamoto S; Xu M; Yamada Y; Rii J; Kanaoka S; Wei J; Zhao X; Pae S; Kanesaka M; Goto Y; Sazuka T; Imamura Y; Reien Y; Hamaguchi-Suzuki N; Saito S; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
    Cancer Sci; 2024 Jul; 115(7):2461-2472. PubMed ID: 38655663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.